EAH Stock Overview
Develops, registers, and markets pharmaceutical products for animals worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ECO Animal Health Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.66 |
| 52 Week High | UK£1.35 |
| 52 Week Low | UK£0.60 |
| Beta | 0.030 |
| 11 Month Change | -2.22% |
| 3 Month Change | -38.60% |
| 1 Year Change | -38.60% |
| 33 Year Change | -58.75% |
| 5 Year Change | -68.57% |
| Change since IPO | 98.00% |
Recent News & Updates
Recent updates
The Price Is Right For ECO Animal Health Group plc (LON:EAH) Even After Diving 31%
Oct 02
ECO Animal Health Group plc (LON:EAH) Soars 28% But It's A Story Of Risk Vs Reward
Apr 27ECO Animal Health Group plc (LON:EAH) Shares Could Be 46% Below Their Intrinsic Value Estimate
Apr 10Is There An Opportunity With ECO Animal Health Group plc's (LON:EAH) 38% Undervaluation?
Sep 16Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 44%?
Apr 18An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 38% Undervalued
Dec 22Calculating The Fair Value Of ECO Animal Health Group plc (LON:EAH)
Mar 17ECO Animal Health Group's (LON:EAH) Solid Earnings Have Been Accounted For Conservatively
Dec 02ECO Animal Health Group plc (LON:EAH) Shares Could Be 48% Below Their Intrinsic Value Estimate
Nov 16Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 39%?
Apr 30Analysts Are Betting On ECO Animal Health Group plc (LON:EAH) With A Big Upgrade This Week
Mar 09Investors Who Bought ECO Animal Health Group (LON:EAH) Shares A Year Ago Are Now Up 58%
Mar 06Is ECO Animal Health Group (LON:EAH) Using Too Much Debt?
Feb 08
An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 49% Undervalued
Dec 18Shareholder Returns
| EAH | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -4.3% | -2.3% | 0.7% |
| 1Y | -38.6% | -2.8% | 6.1% |
Return vs Industry: EAH underperformed the UK Pharmaceuticals industry which returned -2.8% over the past year.
Return vs Market: EAH underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
| EAH volatility | |
|---|---|
| EAH Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EAH's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: EAH's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 227 | David Hallas | www.ecoanimalhealthgroupplc.com |
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
ECO Animal Health Group plc Fundamentals Summary
| EAH fundamental statistics | |
|---|---|
| Market cap | UK£44.72m |
| Earnings (TTM) | UK£1.05m |
| Revenue (TTM) | UK£89.42m |
42.7x
P/E Ratio0.5x
P/S RatioIs EAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EAH income statement (TTM) | |
|---|---|
| Revenue | UK£89.42m |
| Cost of Revenue | UK£51.74m |
| Gross Profit | UK£37.68m |
| Other Expenses | UK£36.64m |
| Earnings | UK£1.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.015 |
| Gross Margin | 42.14% |
| Net Profit Margin | 1.17% |
| Debt/Equity Ratio | 0% |
How did EAH perform over the long term?
See historical performance and comparison